Drug development is facing change – both from technological pressures, such as the use of AI and machine learning, plus new regulations which are driving sweeping changes to the way electronic records are created and stored for clinical trials.
Interviews
25 August 2015
Continuing her company profiles, Sophia Ktori finds that Waters NuGenesis is differentiated because it can capture data from any instrument in the laboratory
07 July 2015
Continuing her series profiling companies providing informatics software, Sophia Ktori looks at the innovative technology of Core Informatics
07 July 2015
Sophia Ktori profiles IDBS, a company focusing on analytics as well as informatics
24 April 2015
Lonza Biosciences MODA system offers not just a paperless but a mobile and sanitisable way to carry out microbiology testing. Sophia Ktori reports
24 April 2015
Autoscribes LIMS has more than the usual applications, from lotteries to vehicle rentals, as Sophia Ktori discovers
10 February 2015
What happens when a relatively small informatics company is acquired by a very large healthcare corporation? Tom Wilkie looks at the case of Abbott Informatics and Starlims
Pages
Latest issue
Robert Roe speaks with laboratory informatics software providers about the future of their software and the introduction of new technologies, such as AI and deep learning
Scientists are now beginning to use new technologies such as the internet of things (IoT), artificial intelligence (AI) and machine learning (ML) in their daily workflows.
In today’s world, where drug development integrates science and technology, consumer safety is paramount in the pharmaceutical industry.